Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (12)

2024

  1. Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights

    Brain Pathology, Vol. 34, Núm. 4

2022

  1. CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington’s disease

    Acta Neuropathologica Communications, Vol. 10, Núm. 1

  2. Correction to: CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in Huntington’s disease (Acta Neuropathologica Communications, (2022), 10, 1, (83), 10.1186/s40478-022-01379-8)

    Acta Neuropathologica Communications

  3. New, Fully Implantable Device for Selective Clearance of CSF-Target Molecules: Proof of Concept in a Murine Model of Alzheimer's Disease

    International journal of molecular sciences, Vol. 23, Núm. 16

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2018

  1. Targeting beta-amyloid at the CSF: A new therapeutic strategy in Alzheimer's disease

    Frontiers in Aging Neuroscience, Vol. 10, Núm. APR

2014

  1. Overexpression of synphilin-1 promotes clearance of soluble and misfolded alpha-synuclein without restoring the motor phenotype in aged A30P transgenic mice

    Human Molecular Genetics, Vol. 23, Núm. 3, pp. 767-781

2012

  1. α-Synuclein accumulates in huntingtin inclusions but forms independent filaments and its deficiency attenuates early phenotype in a mouse model of Huntington's disease

    Human Molecular Genetics, Vol. 21, Núm. 3, pp. 495-510

  2. α-synuclein levels affect autophagosome numbers in vivo and modulate Huntington disease pathology

    Autophagy

2011

  1. Increased neurotransmitter release at the neuromuscular junction in a mouse model of polyglutamine disease

    Journal of Neuroscience, Vol. 31, Núm. 3, pp. 1106-1113

2010

  1. Presynaptic dysfunction in Huntington's disease

    Biochemical Society Transactions, Vol. 38, Núm. 2, pp. 488-492

2009

  1. Effects of partial suppression of parkin on huntingtin mutant R6/1 mice

    Brain Research, Vol. 1281, pp. 91-100